Stay updated on Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Sign up to get notified when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.

Latest updates to the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry, v3.6.6, was added to the record history and the older revision v3.6.5 was removed, indicating an update to the study record.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a minor internal update to the page. This does not affect the study data or public content.SummaryDifference0.0%

- Check51 days agoChange DetectedA new revision entry (v3.6.4) was added to the record history, replacing the previous v3.6.3. This update indicates a version bump in the page's revision history.SummaryDifference0.0%

- Check73 days agoChange DetectedThe revision in the history was updated from v3.6.2 to v3.6.3. This represents a new site version rather than changes to the trial data or content.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing the previous v3.6.0, indicating an updated revision label for the page history.SummaryDifference0.0%

- Check94 days agoChange DetectedThe record adds a recruitment status noting that no participants are being sought, and a new revision tag (v3.6.0) replaces the previous revision (v3.5.5) in the history.SummaryDifference0.1%

Stay in the know with updates to Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.